Does the use of non-steroidal anti-inflammatory drugs after cardiac surgery increase the risk of renal failure?

Interactive Cardiovascular and Thoracic Surgery

Volumn 11, Issue 4, 2010, Pages 461-467

  Acharya, Metesh ^a   Dunning, Joel ^b  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Analgesia; Cardiac surgery; Non steroidal anti inflammatory drug; Pain relief; Renal failure

Indexed keywords

CREATININE; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; ETODOLAC; INDOMETACIN; KETOPROFEN; KETOROLAC; NAPROXEN; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PARECOXIB; PLACEBO; TRAMADOL; VALDECOXIB;

ARTICLE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; HEART SURGERY; HUMAN; KIDNEY FAILURE; OLIGURIA; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; UREA BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARDIAC SURGICAL PROCEDURES; HUMANS; PAIN, POSTOPERATIVE; RENAL INSUFFICIENCY; RISK FACTORS;

EID: 78249258113     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2010.239053     Document Type: Article

References (12)

1. Dunning J, Prendergast B, Mackway-Jones K. Towards evidence-based medicine in cardiothoracic surgery: best BETS. Interact CardioVasc Thorac Surg 2003;2:405-409.
2. Bainbridge D, Cheng DC, Martin JE, Novick R, Evidence-Based Perioperative Clinical Outcomes Research (EPiCOR) Group. NSAID-analgesia, pain control and morbidity in cardiothoracic surgery. Can J Anaesth 2006;53:46-59.
3. Fayaz MK, Abel RJ, Pugh SC, Hall JE, Djaiani G, Mecklenburgh JS. Opioid-sparing effects of diclofenac and paracetamol lead to improved outcomes after cardiac surgery. J Cardiothorac Vasc Anesth 2004;18:742-747.
4. Gupta A, Daggett C, Drant S, Rivero N, Lewis A. Prospective randomized trial of ketorolac after congenital heart surgery. J Cardiothorac Vasc Anesth 2004;18:454-457.
5. Hynninen MS, Cheng DC, Hossain I, Carroll J, Aumbhagavan SS, Yue R, Karski JM. Non-steroidal anti-inflammatory drugs in treatment of postoperative pain after cardiac surgery. Can J Anaesth 2000;47:1182-1187.
6. Nussmeier NA, Whelton AA, Brown MT, Langford RM, Hoeft A, Parlow JL, Boyce SW, Verburg KM. Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med 2005;352:1081-1091
7. Ott E, Nussmeier NA, Duke PC, Feneck RO, Alston RP, Snabes MC, Hubbard RC, Hsu PH, Saidman LJ, Mangano DT, Multicenter Study of Perioperative Ischemia (McSPI) Research Group; Ischemia Research and Education Foundation (IREF) Investigators. Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg 2003;125:1481-1492.
8. Immer FF, Immer-Bansi AS, Trachsel N, Berdat PA, Eigenmann V, Curatolo M, Carrel TP. Pain treatment with a COX-2 inhibitor after coronary artery bypass operation: a randomized trial. Ann Thorac Surg 2003;75:490-495.
9. Kulik A, Ruel A, Bourke ME, Sawyer L, Penning J, Nathan HJ, Mesana TG, Bédard P. Postoperative naproxen after coronary artery bypass surgery: a double-blind randomized controlled trial. Eur J Cardiothorac Surg 2004;26:694-700.
10. Inoue M, Caldarone CA, Frndova H, Cox PN, Ito S, Taddio A, Guerguerian AM. Safety and efficacy of ketorolac in children after cardiac surgery. Intensive Care Med 2009;35:1584-1592.
11. Moffett BS, Wann TI, Carberry KE, Mott AR. Safety of ketorolac in neonates and infants after cardiac surgery. Paediatr Anaesth 2006;16:424-428.
12. Dawkins TN, Barclay CA, Gardiner RL, Krawczeski CD. Safety of intravenous use of ketorolac in infants following cardiothoracic surgery. Cardiol Young 2009;19:105-108.